Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT. - Trial NCT06227611
Access comprehensive clinical trial information for NCT06227611 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione G.B. Bietti, IRCCS and is currently Recruiting. The study focuses on Glaucoma. Target enrollment is 16 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Fondazione G.B. Bietti, IRCCS
Timeline & Enrollment
N/A
May 04, 2021
May 04, 2025
Primary Outcome
the agreement between 10-2 HFA and 24-2c HFA in detecting central visual field defect
Summary
The aim of the study is to evaluate the agreement between three different grids in detecting
 central visual field defect in early glaucoma patients with reduced ganglion cell layer
 thickness.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06227611
Non-Device Trial